Cite
HARVARD Citation
Morgan, G. et al. (n.d.). Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM‐003 trial for pomalidomide plus low‐dose dexamethasone. British journal of haematology. pp. 820-823. [Online].